Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 8 of 8 entries
View as:

Medical Nutrition Formulations Enriched with Postbiotics for the Management of Gastrointestinal Disorders

Phase: N/A Priority: Normal
NCT ID: NCT06738420 Org: User:
Start: 01/27/23 End: 04/04/24 Due: 04/04/25

Efficacy and Tolerability of ABBC1 in Volunteers Receiving the Influenza or Covid-19 Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04798677 Org: User:
Start: 10/29/20 End: 09/24/21 Due: 09/24/22

Kinetic Study Of Supplementation With The Enzyme Diamine Oxidase In Patients With Histamine Intolerance

Phase: N/A Priority: Normal
NCT ID: NCT07006558 Org: User:
Start: 06/23/23 End: 08/05/24 Due: 08/05/25

DAO DEFICIENCY SCREENING AMONG PATIENTS WITH INSOMNIA SYMPTOMS

Phase: N/A Priority: Normal
NCT ID: NCT06488027 Org: User:
Start: 05/05/23 End: 11/27/23 Due: 11/27/24

Evaluation Of The Diamine Oxidase Supplementation Effect In Patients With Insomnia Symptoms

Phase: N/A Priority: Normal
NCT ID: NCT07027943 Org: User:
Start: 03/13/24 End: 12/18/24 Due: 12/18/25

Efficacy and Tolerability of ABB I5 Prebiotic and ABB C22 Postbiotics for the Management of Constipation and Gastrointestinal Well-being: a Pilot Trial

Phase: N/A Priority: Normal
NCT ID: NCT06738433 Org: User:
Start: 04/25/23 End: 04/04/24 Due: 04/04/25

Prevalence of DAO (diamino Oxidase) Deficiency in Newborns

Phase: N/A Priority: Normal
NCT ID: NCT06710366 Org: User:
Start: 02/28/23 End: 06/26/24 Due: 06/26/25

Evaluation of the Safety and Tolerability of Three Doses of Diamine Oxidase (DAO) in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06715163 Org: User:
Start: 07/08/24 End: 07/29/24 Due: 07/29/25